Related Experiment Videos
Flecainide plasma concentrations correlated to inhibition of a bundle of Kent
British Journal of Clinical Pharmacology
|August 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
The relative dose intensity of first-line FOLFOXIRI and FOLFOX/FOLFIRI both in combination with bevacizumab affects prognosis of metastatic colorectal cancer patients: A pooled analysis of TRIBE and TRIBE2 studies.
European journal of cancer (Oxford, England : 1990)·2025
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project.
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2020
Impact of age and gender on the safety and efficacy of chemotherapy plus bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Machine learning framework for prediction of drug-induced liver injury in patients on antitubercular therapy: Multicentric study.
British journal of clinical pharmacology·2026
Translational development of crisugabalin for neuropathic pain.
British journal of clinical pharmacology·2026
Physiologically based pharmacokinetic modelling of levofloxacin as a tool for paediatric dose optimization.
British journal of clinical pharmacology·2026
Patient-reported outcomes and medication errors during oral antitumour therapy in paediatrics: Results from the youngAMBORA care programme.
British journal of clinical pharmacology·2026
Analysis of clinical investigation (device) initial submissions received by the Medicines and Healthcare products Regulatory Agency between January 2022 and December 2025.
British journal of clinical pharmacology·2026
Ceftriaxone-associated immune haemolytic anaemia: A patient-level systematic review.
British journal of clinical pharmacology·2026
Pharmacovigilance in the treatment of cutaneous leishmaniasis: adverse event profile at a reference center.
Revista da Sociedade Brasileira de Medicina Tropical·2026
Total synthesis as a critical tool for structural revision of natural products.
Chemical communications (Cambridge, England)·2026
Progress on quinoline‑based antitumour agents: Mechanistic insights and optimization strategies (Review).
Molecular medicine reports·2026
Disproportionate reporting of seizures with histamine H1 receptor antagonists: The role of drug generation and brain H1 receptor occupancy assessed using the Japanese Adverse Drug Event Report database.
International journal of clinical pharmacology and therapeutics·2026